Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia.

Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia.

BACKGROUND:High frequency of relapse in miltefosine-treated visceral leishmaniasis (VL) patients in India and Nepal followed up for twelve months. OBJECTIVE:To identify epidemiological and clinical risk factors for relapse of VL in patients recently treated with standard dosing of miltefosine in Ind...

Full description

Bibliographic Details
Main Authors:	Bart Ostyn, Epco Hasker, Thomas P C Dorlo, Suman Rijal, Shyam Sundar, Jean-Claude Dujardin, Marleen Boelaert
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4062493?pdf=render

Similar Items

Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control.
by: Anette Stauch, et al.
Published: (2011-11-01)

Xenodiagnosis to address key questions in visceral leishmaniasis control and elimination.
by: Om Prakash Singh, et al.
Published: (2020-08-01)

Model-based investigations of different vector-related intervention strategies to eliminate visceral leishmaniasis on the Indian subcontinent.
by: Anette Stauch, et al.
Published: (2014-04-01)

Long-lasting insecticidal nets to prevent visceral leishmaniasis in the Indian subcontinent; methodological lessons learned from a cluster randomised controlled trial.
by: Albert Picado, et al.
Published: (2015-04-01)

Risk factors for visceral leishmaniasis and Leishmania donovani infection in the Indian subcontinent
by: A. Picado, et al.
Published: (2014-04-01)

Visceral Leishmaniasis in Rural Bihar, India
by: Epco Hasker, et al.
Published: (2012-10-01)

Relapse after Treatment with Miltefosine for Visceral Leishmaniasis Is Associated with Increased Infectivity of the Infecting <named-content content-type="genus-species">Leishmania donovani</named-content> Strain
by: Keshav Rai, et al.
Published: (2013-11-01)

Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.
by: Vasundhra Bhandari, et al.
Published: (2012-01-01)

Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal.
by: Epco Hasker, et al.
Published: (2014-01-01)

Male predominance in reported Visceral Leishmaniasis cases: Nature or nurture? A comparison of population-based with health facility-reported data.
by: Kristien Cloots, et al.
Published: (2020-01-01)

Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent.
by: Filip Meheus, et al.
Published: (2010-09-01)

Domestic Animals and Epidemiology of Visceral Leishmaniasis, Nepal
by: Narayan Raj Bhattarai, et al.
Published: (2010-02-01)

Visceral Leishmaniasis-HIV Coinfection as a Predictor of Increased Leishmania Transmission at the Village Level in Bihar, India
by: Kristien Cloots, et al.
Published: (2021-03-01)

Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India.
by: Caroline A Bulstra, et al.
Published: (2018-12-01)

Visceral Leishmaniasis and HIV coinfection in East Africa.
by: Ermias Diro, et al.
Published: (2014-06-01)

Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis
by: Sankha Koley, et al.
Published: (2013-01-01)

Glutamine supplementation improves the efficacy of miltefosine treatment for visceral leishmaniasis.
by: Carolina Ferreira, et al.
Published: (2020-03-01)

Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study.
by: Jaya Chakravarty, et al.
Published: (2019-03-01)

Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000-2010).
by: Surendra Uranw, et al.
Published: (2011-12-01)

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.
by: Monique Wasunna, et al.
Published: (2016-09-01)

Serological markers of sand fly exposure to evaluate insecticidal nets against visceral leishmaniasis in India and Nepal: a cluster-randomized trial.
by: Kamlesh Gidwani, et al.
Published: (2011-09-01)

Oral miltefosine treatment in children with visceral leishmaniasis: a brief review
by: Emilio Palumbo

Diagnosis of Visceral Leishmaniasis in an Elimination Setting: A Validation Study of the Diagnostic Algorithm in India
by: Kristien Cloots, et al.
Published: (2022-03-01)

Source Tracing of Leishmania donovani in Emerging Foci of Visceral Leishmaniasis, Western Nepal
by: Pieter Monsieurs, et al.
Published: (2024-03-01)

Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
by: Hideo Imamura, et al.
Published: (2016-03-01)

Impact of the visceral leishmaniasis elimination initiative on Leishmania donovani transmission in Nepal: a 10-year repeat survey
by: Kristien Cloots, MD, et al.
Published: (2020-02-01)

Clinical and Laboratory Response of Domiciled Dogs with Visceral Leishmaniasis Treated with Miltefosine and Allopurinol
by: Talita Pereira Vaz, et al.
Published: (2023-10-01)

Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis.
by: Andrew A Voak, et al.
Published: (2021-03-01)

Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil
by: Fabio dos Santos Nogueira, et al.
Published: (2019-02-01)

Post kala azar dermal leishmaniasis and leprosy prevalence and distribution in the Muzaffarpur health and demographic surveillance site.
by: Epco Hasker, et al.
Published: (2019-10-01)

Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh.
by: Ridwanur Rahman, et al.
Published: (2017-05-01)

Dynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosine.
by: Thomas P C Dorlo, et al.
Published: (2011-12-01)

Visceral leishmaniasis in the hills of western Nepal: A transmission assessment
by: Surendra Uranw, et al.
Published: (2024-01-01)

Control of visceral leishmaniasis in latin america-a systematic review.
by: Gustavo A S Romero, et al.
Published: (2010-01-01)

Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal
by: E. Hasker, et al.
Published: (2014-04-01)

Epidemiology of visceral leishmaniasis in Algeria: an update.
by: Amel Adel, et al.
Published: (2014-01-01)

Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent?
by: Meghan R Perry, et al.
Published: (2011-09-01)

Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial
by: Kinoti Dedan, et al.
Published: (2011-06-01)

A comparative evaluation of the performance of commercially available rapid immunochromatographic tests for the diagnosis of visceral leishmaniasis in Bangladesh
by: Prakash Ghosh, et al.
Published: (2015-06-01)

Epidemiology and clinical features of patients with visceral leishmaniasis treated by an MSF clinic in Bakool region, Somalia, 2004-2006.
by: Marie-Eve Raguenaud, et al.
Published: (2007-10-01)